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Abstract  14 
 15 
Since the novel SARS-CoV-2 was detected in faeces, environmental researchers have been using 16 
centrifugal ultrafiltration, polyethylene glycol precipitation and aluminium hydroxide flocculation to 17 
describe its presence in wastewater samples. High recoveries (up to 65%) are described with 18 
electronegative filtration when using surrogate viruses, but few literature reports recovery efficiencs 19 
using accurate quantification of enveloped viruses. Considering that every single virus will have a 20 
different behaviour during viral concentration, it is recommended to use an enveloped virus, and if 21 
possible, a betacoronaviruses as murine hepatitis viru (MHV), as a surrogate. In this review we show 22 
new data from a new available technology that provides a quick ultrafiltration protocol for SARS-23 
CoV-2. Wastewater surveillance is an efficient system for the evaluation of the relative prevalence of 24 
SARS-CoV-2 infections in a community, and there is the need of using reliable concentration 25 




Many viruses that infect humans are excreted in large amounts through faeces and urine or skin 30 
desquamation, contributing to wastewater virome. Wastewater is a complex matrix that comprises a 31 
large variety of pathogenic and commensal viruses and provides important information about virus 32 
circulation, the introduction of emergent viruses and how they are transmitted among the population 33 
[1]. Waterborne viruses are generally non enveloped an  excreted in high numbers by infected 34 








study of excreted viruses is a very useful tool know  as  Wastewater-Based Epidemiology (WBE), 36 
which has the potential to act as a complementary appro ch for current infectious disease surveillance 37 
systems and an early warning system for disease outbreaks [3].    38 
 39 
The incidence of emerging microbes is a serious health concern worldwide. The increase of human-40 
livestock contacts [4], population mobility and trade networks [5,6], climate change [7] or the wild 41 
meat trade and loss of animal habitats [8] has raised the risk of a global pandemics. Since 1980, nearly 42 
90 novel human pathogen species have been discovered, more than 70 of those corresponded to novel 43 
human viruses, that compared to other pathogens have t e potential to evolve more rapidly, being 80 44 
of these associated with nonhuman reservoirs [9,10]. Influenza viruses (H1N1, H7N1, H7N9), human 45 
immunodeficiency virus (HIV), ebola virus, coronaviruses as SARS-CoV, MERS, and the SARS-46 
CoV-2 causing the COVID-19 pandemic have been the most significant.   47 
 48 
SARS-CoV-2 was identified in China at the end of 2019 [11] and has become the first pandemic 49 
coronavirus (CoV). After the first case report of the presence of SARS-CoV-2 RNA in faeces [12], 50 
and because of the presence in the past of SARS-CoV-1 in feces and sewage [13–15], the scientific 51 
community started to investigate if this virus could spread into the environment. Specific stability of 52 
SARS-CoV-2 has only been tested in aerosols and surfaces [16], but it is known that enveloped virus 53 
are capable of retaining infectivity for days to months in aqueous environments [17–19]. On March 54 
30th, SARS-CoV-2 was reported as detectable in wastewater three weeks before the first case was 55 
reported in the Netherlands [20]. On the following weeks, studies from Australia, China, Italy and 56 
Spain, reported the presence of SARS-CoV-2 and concentrations in raw wastewater to be between 57 
104-106 GC/L [21–24].  58 
 59 
One of the major challenges in SARS-CoV-2 research in wastewater samples is the lack of 60 
standardized protocols for its detection. From sample collection to virus concentration, there is still no 61 
consensus on the most efficient procedure. The way the sample is collected, or the virus is 62 
concentrated seems to be crucial in order to avoid false negative results or inaccurate reported 63 
concentrations. Although viral titers in composite samples are being reported to be lower than in non-64 
composite ones, the persistent variability between no -composite replicates suggest using an 65 
autosampler that collects a volume proportional to f ow as the best sampling strategy. Also, the fact 66 
that different studies use different nucleic acid extraction and detection methods made difficult to 67 
establish comparisons among different studies. 68 
After conducting an extensive revision on the most c mmonly used methods for concentrating viruses 69 
from wastewater samples in the last two years, Bofill-Mas and Rusiñol (2020) described that viral 70 
concentration methods had been mostly focused on combinations of flocculation/precipitation 71 








viruses and also DNA viruses abundantly excreted in feces, urine o desquamation as adenoviruses, 73 
polyomaviruses and papillomaviruses, which are all non-enveloped virus [2]. In fact, in 2015, 74 
Wigginton and collaborators noticed that research should focus on the study of enveloped viruses in 75 
the urban water cycle as future pandemics could involve this type of viruses [26].  76 
This review provides a brief on what it is known about the efficiency of viral concentration methods 77 
for CoV as well as for other enveloped viruses and new data of a comparative study analysing three 78 
concentration methods, skimmed milk flocculation, a new quick technology for ultrafiltration and a 79 
centrifugal ultrafiltration protocol. 80 
 81 
SARS-CoV-2 in wastewater studies. 82 
 83 
To date, the published SARS-CoV-2 surveillance studies use centrifugal ultrafiltration (CeUF) 84 
[20,21],  methods including polyethylene glycol (PEG) or aluminium hydroxide (Al(OH)3  85 
flocculation-precipitation [22–24] to concentrate SARS-CoV-2 from untreated wastewater. Figure 1 86 
summarizes the methods used in recently published stu ie  to concentrate SARS-CoV-2 from 87 
wastewater samples.  88 
As wastewater becomes a surveillance tool for potential i cidence regrowth, the interest to understand 89 
the performance of the concentration methods used increases as well as the interest towards those 90 
methods developed and validated for non-enveloped viruses testing. Culturing SARS-CoV-2 requires 91 
BSL-3 laboratories and specially trained personnel, thus the use of surrogate CoV (e.g. non-human 92 
infectious CoV strains, or other enveloped viruses) should be considered for methods development or 93 
as positive control at this stage of research.  94 
 95 
La Rosa et al. [27] recently published a review on CoV in water environments, including data on 96 
occurrence, persistence and survival. Also Carducci et al. [28] revised the current state of the art 97 
regarding CoV in water and highlighted the research gaps of the methods commonly used for 98 
sampling and concentration of enteric viruses which need to adapt to enveloped viruses. Both reviews 99 
are focused in the 4 available studies on human CoVthat use two-step methodologies based on a pre-100 
centrifugation and ultrafiltration [18], glass wool filtration and PEG elution [29,30] and 101 
electropositive filter media columns and PEG precipitation [31]. Kitajima et al. [32] reviewed the 102 
state of the knowledge regarding the potential role of wastewater in the transmission of SARS-CoV-2.  103 
 104 
The mouse hepatitis (MHV), a surrogate for human CoV, has been used for persistence, survival and 105 
method comparison studies [18,33,34]. Ye et al. [18] compared, by means of MHV recoveries, three 106 
methodologies to concentrate enveloped viruses from wastewater samples, PEG precipitation and 107 
ultracentrifugation recovered approximately 5% of the spiked viruses whereas with ultrafiltration 108 








removal of debris, prefiltering 250 mL of wastewater through a 0.22 μm PES membrane, followed by 110 
Centricon® Plus-70 10 kDa filtration. Recently, Ahmed et al. [34] have also evaluated six 111 
concentration strategies using MHV as a surrogate. Th  three filtration methods assayed provided 112 
highest mean recoveries: when MgCl2 pre-treatment was included 65% of the MHV were recov red, 113 
when sample was directly filtered through 0.45-μm pore-size electronegative membranes, MHV 114 
recoveries were 60%, but when pre-acidifying the sample the mean recovery decreased to 27%. 115 
Between the two CeUF methods tested, the Amicon® Ultra-15 30KDa recovered 56% of the spiked 116 
surrogate and Centricon® Plus-70 10KDa recovered 28%. Finally, by means of PEG precipitation and 117 
ultracentrifugation, MHV recoveries were 44% and 33% respectively. 118 
 119 
Although some enveloped viruses could be adequate surrogates for betacoronavirus concentration, 120 
only 5/15 published studies on SARS-CoV-2 occurrence in wastewater have used whole process 121 
controls, some non-enveloped virus including RNA phages [20] and Mengo virus [22], and an 122 
enveloped virus as porcine epidemic diarrhea virus (PEDV) [22]. The use of these controls prove that 123 
the protocol worked correctly and provide with an estimation of the recovery efficiency of the method 124 
for the control, although this could be different for the virus of interest. Highest recoveries were 125 
obtained with CeUF devices, like Centricon® Plus-70 30KDa, reaching 73% of the seeded F-specific 126 
RNA phages [20]. Randazzo et al. [22] used a surrogate CoV to calculate recovery. It is remarkable 127 
that with the Al(OH)3 flocculation method a similar recovery (11%) was obtained for the enveloped 128 
virus, PEDV, and the non-enveloped virus, Mengo virus. Different viruses, even those sharing 129 
physical properties, use to show a different recovery when concentrated by the same method. To 130 
observe similar recovery values could have been a mere casualty or it could be that both viruses 131 
attached to flocs with similar efficiencies due to their negative charge when they are above the 132 
isoelectric point [35]. 133 
 134 
Preliminary data obtained by our research group in a study analysing different concentration methods 135 
for the detection of SARS-CoV-2 in wastewater from Catalonia (Spain), using MS2 as a process 136 
control, showed no statistically significant differences (p-value of the ANOVA test: 0,332) between 137 
the quantitative data (RT-qPCR) produced by the thre viral concentration methods both for SARS-138 
CoV-2 and for MS2. Four wastewater samples were concentrated using: the Skimmed Milk 139 
Flocculation (SMF) protocol [36] with an initial sample volume of 250 ml, the centrifugal 140 
ultrafiltration of 70 ml of the sample with Centricon® Plus-70 100 kDa (CeUF) [20] and a new and 141 
quick 80 ml ultrafiltration protocol using the automatic Concentrating Pipette (CP-Select™) from 142 
Innovaprep using 150 kDa ultrafiltration tips (www.innovaprep.com) (Figure 2). Debris were 143 
removed before the ultrafiltration by pelleting using centrifugation at 4750xg for 30 mins. A volume 144 









Concentration of other enveloped viruses with pandemic potential in wastewater 147 
 148 
On the lack of much data regarding CoV recovery effici ncy when using commonly applied methods 149 
and until more data will be available, we should rely on what it is known for other enveloped viruses 150 
considering that every single virus will have a different behaviour during viral concentration. Alone or 151 
combined, the electropositive and electronegative filtration, CeUF, the organic flocculation and the 152 
PEG/Al(OH)3 precipitation methods, have been used in different studies covering enveloped viruses’ 153 
detection in environmental waters. Table 1, revises the concentration methods used until now for 154 
enveloped virus and summarises a selection of studies reporting recovery efficiencies. 155 
 156 
It has been reported that higher percentage of enveloped viruses adsorb to the solid fraction of 157 
wastewater compared to non-enveloped viruses [18] and it is believed that these suspended solids 158 
protect viruses from inactivation [19,37,38]. None of the published studies included the first step 159 
separated solids into the analysis, but most of them involved an initial step to remove wastewater 160 
solids and then focused on recovering the viruses from the liquid phase.  161 
 162 
Despite the proposed viral concentration methods for SARS-CoV-2 or generally for CoV, extensively 163 
reviewed by others, the organic flocculation, has been also used for the concentration of viruses in 164 
water including enveloped viruses. The enveloped virus, bovine viral diarrhea virus (BVDV), 165 
presented mean recoveries of 15% when tested with qPCR and 0,7% when tested for infectivity, but 166 
acid pH (for approximately 16h) that is used in theSMF protocol seems to reduce the infectivity, as 167 
the Log10 ratio RT-qPCR/infectivity for that virus was 2.03 [ 6,39,40]. The same observation has 168 
been described for PEG precipitation methods which disrupt the lipid bilayers and thus are not 169 
optimal for recovering infective enveloped viruses [18,41]. 170 
 171 
When testing viral recovery methods, it is relevant to consider how recovery rates are calculated and 172 
at this point the quantification of viral stocks used for spiking is of relevance since different values 173 
may be obtained when the quantification is done dirctly from viral stocks used for spiking or when 174 
quantifying after adding viral stock into a similar matrix from which recovered viruses will be 175 
quantified. Different enzymatic inhibition could be observed depending on the matrix in which 176 
viruses are embedded. On the other hand, if recovery is calculated according to infectivity by means 177 
of plaque forming unit’s quantification assays, viral aggregation phenomena could lead to an under 178 
quantification of viral stocks. Disaggregation protocols before spiking should be considered to correct 179 
this effect [42]. Finally, direct quantification ofviral stocks without pre-purification or enzymatic pre-180 
treatment may overestimate the real amount of infectious viruses as the presence of free RNA may be 181 









Future research directions and conclusions  184 
 185 
Agents causing novel infections are often zoonotic, crossing from the natural host into the human 186 
population. Hence, a one-health surveillance approach f virus-infected animals as well as humans is 187 
required. Structural and biochemical differences betwe n enveloped viruses suggest that the same 188 
methods would not exhibit the same recoveries between them. As there is a potential for new 189 
outbreaks, the molecular detection of SARS-CoV-2 RNA in wastewater and the correlation between 190 
its concentration and reported prevalence of COVID19 may be a sensitive monitoring tool to evaluate 191 
the prevalence of the virus in a community, becoming a potential source of epidemiological data and 192 
public health risks information [20].  193 
 194 
In order to face off novel outbreaks important public health organizations such as CDC, ECDC or 195 
WHO, highlight the role of scientific research to cmbat infectious disease, especially those emerging 196 
or re-emerging disease that may reappear in a more threating form. CDC establishes that detection 197 
and identification should be prioritized by expanding research on ecologic and environmental factors 198 
influencing disease emergence and transmission, meanwhile the ECDC highlights as a general 199 
surveillance objective, detect and monitor food- and waterborne and zoonotic outbreaks with respect 200 
to source, time, population and place in order to provide a rationale for public health actions. On the201 
other hand, one of the WHO actions is to provide an integrated global alert and response system for 202 
epidemics and other public health emergencies for an effective international coordinated response. 203 
More scientific research is needed to identify viral t nsmission routes, characterizing protocols and 204 
early detection strategies for a better understanding of the factors involved in disease emergence, 205 
prevention, and elimination. In order to furnish health management models with wastewater 206 
surveillance data, more research should focus on optimizing and evaluating concentration methods 207 
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Table 1. Concentration methods and mean recoveries for enveloped viruses 
Sample 
type 









Ultrafiltration (Centricon® Plus-70 100kDa) 25,1 ± 3,6% (PFU) 
[18] PEG/NaCl flocculation-precipitation 5% (PFU) 
Ultracentrifugation 1% (PFU) 
Ultrafiltration (Centricon® Plus-70 30KDa) 28,0 ± 9,10% (qPCR) 
[34] 
Ultrafiltration (Amicon® Ultra-15 30KDa) 56,0 ± 32,3% (qPCR) 
Electronegative filtration (pre-acidification) 26,7 ± 15,3% (qPCR) 
Electronegative filtration (direct filtration) 60,5 ± 22,2% (qPCR) 
Electronegative filtration (pre-treated MgCl2) 65,7 ± 23,0% (qPCR) 
PEG/NaCl flocculation-precipitation 44,0 ± 27,7% (qPCR) 
Ultracentrifugation 33,5 ± 12,1% (qPCR) 
SARS-CoV Positive charged filter media + PEG elution 1,02% (TCID50 )  [31] 
PEVD Al(OH)3 flocculation-precipitation 
Influent 10,90 ± 3,54% (qPCR) 





Ultrafiltration (Centricon® Plus-70 100kDa) 18,2 ± 9,5% (PFU) 
[18] PEG/NaCl flocculation-precipitation 5% (PFU) 





Ultrafiltration (Centricon® Plus-70 30KDa) 
Influent 53,8% (qPCR) 








Glass wool (electropositive filtration) + 20% 
PEG elution 




Glass wool (electropositive filtration) + 10% 
PEG elution 
Low turbidity 0,5 NTU: 25,8 ± 21,3% (qPCR) 
Medium turbidity 125 NTU: 9,2 ± 2,4% (qPCR) 






type 1  
Glass wool (electropositive filtration)+ 10% 
PEG elution 
Low turbidity 0,5 NTU: 12,9 ± 5,4% (qPCR) 
Medium turbidity 125 NTU: 12,9 ± 13,3% (qPCR) 
High turbidity 447 NTU: 21,1 ± 5,3% (qPCR) 
[29] 
BVDV Skimmed Milk flocculation 
15 ± 1,6% (qPCR)   






Glass wool (electropositive filtration)+ 10% 
PEG elution 
River water 1% (TCID50) 










MHV: murine hepatitis virus; PEVD: porcine epidemic diarrhea virus; TGEV: transmissible gastroenteritis virus; BVDV: bovine viral diarrhea virus; BCoV: Bovine 3 
coronavirus. 4 
 5 
Lake water 0,01-7,89% (qPCR) 
Ultrafiltration (Hemoflow F80S) Surface water 5,4% (qPCR) [44] 
Influenza A 
(H5N3) 
Pre-filtration + borosilicate glass membrane 
GF/F (electropositive filtration) 
Riverwater: 4.7 ± 0.05% (qPCR) 
Seawater: 16.7 ± 0.04% (qPCR) 
[46] 
Electronegative filtration (SMWP membranes) 
Riverwater: 1.5 ± 0.01% (qPCR) 

























Figure 1: Summary of the diferent strategies used in the published literature to concentrate SARS-CoV-2 from wastewater samples. 
PEG/Al(OH)3 flocculation-precipitation based methods [22–24] centrifugal ultrafiltration methods [20,21] and electronegative 











Electronegative filtration          
(pre-conditioning of pH at 3,5) 






























Sample 1 23% 50% 8%
Sample 2 37% 43% 23%
Sample 3 32% 66% 23%























There are efficient methods to concentrate enveloped virus such as coronaviruses 
More data on the recovery of the specific pathogen of interest is needed 
Viral surrogates, ideally betacoronavirus, may be used as SARS-CoV-2 process control 
Recovery calculation needs an accurate quantification of the viral stock 
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